| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107321 FLK-1 is a receptor for vascular endothelial growth factor |
| 05/19/2005 | DE10347386A1 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 05/19/2005 | DE10346939A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 05/19/2005 | CA2543882A1 Aralkyl amines as cannabinoid receptor modulators |
| 05/18/2005 | EP1530574A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | EP1076652B1 N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| 05/18/2005 | EP0998452B1 Liquid crystal propene or propenyl nitrile derivatives |
| 05/18/2005 | CN1617865A Phenylalkynes |
| 05/18/2005 | CN1617858A Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-1) |
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/18/2005 | CN1617744A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 05/18/2005 | CN1616438A Process for preparing alfuzosin hydrochloride |
| 05/18/2005 | CN1202087C Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 05/18/2005 | CN1201821C Stable complex of insoluble chemical compound |
| 05/17/2005 | US6894057 Administering to the living body a oxo-azabicyclo derivative to treat disease selected from arthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, asthma, cancer and macular degeneration |
| 05/17/2005 | US6894051 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 05/17/2005 | US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/17/2005 | CA2267510C Process for manufacturing alpha-1l-adrenoceptor antagonists |
| 05/17/2005 | CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones |
| 05/17/2005 | CA2136597C Hydrazine derivatives and uses thereof |
| 05/12/2005 | WO2005042712A2 Heterocyclic compounds and methods of making and using thereof |
| 05/12/2005 | WO2005042522A1 Process for the manufacture of the calcium salt of rosuvatatin (e)-7-`4- (4-fluorophenyl) -6-isopropyl-2-`methyl (methylsulfonyl) amino ! pyrimidin -5-yl ! (3r, 5s) -3, 5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof |
| 05/12/2005 | WO2005042502A1 Amide derivatives |
| 05/12/2005 | WO2005042501A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 05/12/2005 | WO2005042500A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| 05/12/2005 | WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 05/12/2005 | WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections |
| 05/12/2005 | WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 05/12/2005 | WO2005003100A3 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 05/12/2005 | WO2005003099A3 Pyrimidines useful as modulators of voltage-gated ion channels |
| 05/12/2005 | WO2004113341A3 Fungicidal triazolopyrimidines |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/12/2005 | WO2003074496A8 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms |
| 05/12/2005 | WO2003006454A8 Heterocyclic carboxamides and their use as fungicides |
| 05/12/2005 | US20050101798 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 05/12/2005 | US20050101783 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101620 Selective synthesis of CF3-substituted pyrimidines |
| 05/12/2005 | US20050101617 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
| 05/12/2005 | US20050101616 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 05/12/2005 | US20050101613 Substituted pyrimidine derivatives |
| 05/12/2005 | US20050101609 Quinazoline derivatives as kinase inhibitors |
| 05/12/2005 | US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 05/12/2005 | DE10231496B4 Verfahren zur Herstellung von hochreinem, kristallinem 4-Amino-5,6-dimethoxypyrimidin A process for the preparation of highly pure crystalline 4-amino-5,6-dimethoxypyrimidine |
| 05/12/2005 | CA2543710A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 05/12/2005 | CA2543358A1 Process for the manufacture of the calcium salt of rosuvastatin(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof |
| 05/12/2005 | CA2542047A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors |
| 05/12/2005 | CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| 05/12/2005 | CA2540460A1 Heterocyclic compounds and methods of making and using thereof |
| 05/12/2005 | CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 05/11/2005 | EP1529778A1 Production method of pyrimidine derivative, intermediate therefor |
| 05/11/2005 | EP1529530A1 Compounds affecting glucokinase |
| 05/11/2005 | EP1529036A1 Method for producing highly pure crystalline 4-amino-5,6-dimethoxypyrimidine |
| 05/11/2005 | EP1529032A1 Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2,6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile |
| 05/11/2005 | EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect |
| 05/11/2005 | CN1615301A Dithiocarbamate derivatives and their use as antibacterial agents |
| 05/11/2005 | CN1200940C Triazole pyrimidine compounds |
| 05/11/2005 | CN1200609C Substituted aminomethyl phenyl sulphonyl ureas, their production and their use as herbicides and plant growth regulators |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890930 Quinazolinones |
| 05/10/2005 | US6890924 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 05/10/2005 | CA2278290C Quinazolinone compounds |
| 05/06/2005 | WO2005040163A1 Heterocyclic compounds that block the effects of advanced glycation end products (age) |
| 05/06/2005 | WO2005040135A1 Antistress drug and medical use thereof |
| 05/06/2005 | WO2005040134A1 Process for the preparation of amorphous rosuvastatin calcium |
| 05/06/2005 | WO2005040133A1 Pyrimidine compounds for the treatment of inflammation |
| 05/06/2005 | WO2005040129A2 Ccr3 receptor antagonists |
| 05/06/2005 | WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | WO2005040100A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2005005395A3 Arylamine-substituted quinazolinone compounds |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2543419A1 Ccr3 receptor antagonists |
| 05/06/2005 | CA2542514A1 Pyrimidine compounds for the treatment of inflammation |
| 05/06/2005 | CA2542494A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | CA2541989A1 P70s6 kinase modulators and method of use |
| 05/06/2005 | CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | CA2538134A1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 05/06/2005 | CA2538131A1 Novel triarylimidazoles |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096337 for example (2-(3-methoxy-propyl)-4-{methyl-[2-methyl-6-(4-trifluoromethyl-phenyl)-pyridin-3-ylmethyl]-amino}-phenoxy)-acetic acid; Peroxisome Proliferator Activated Receptor (PPAR) activators; treating diabetes, dyslipidemia, cardiovascular disorders, polycystic ovary syndrome, proliferative disorders |
| 05/05/2005 | US20050096336 Benzannelated derivatives, their manufacture and use as pharmaceutical agents |
| 05/05/2005 | US20050096327 eg 2-(4-Methyl-piperazin-1-yl)-4-phenyl-quinazoline; attention deficit hyperactivity disorder |
| 05/05/2005 | US20050095457 Iridium complexes in electron transport layer of Light-emitting diodes; bright, efficient, stable; low temperature vacuum deposition and preventing decomposition |
| 05/04/2005 | EP1528057A1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of HIV infection |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527345A2 Method for isolating atp binding proteins by means of immobilized protein inhibitors |
| 05/04/2005 | EP1527052A1 3-heterocyclyl substituted benzoic acid derivatives |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP0946177B1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A |
| 05/04/2005 | CN1612864A Novel alkansulfonamides as endothelin antagonists |
| 05/04/2005 | CN1199943C Method of producing aminophenylsulphonyl carbamides and intermediate products for use in the process |
| 05/04/2005 | CN1199939C Derivative containing alkyl sulfanyl hydrazone having insecticide, antibacterial and herbicide activity and preparation method |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |